TG Therapeutics | TGTX - Debt

Stock Price
28.25
Daily Change
0.49 1.77%
Monthly
-6.89%
Yearly
-14.63%
Q1 Forecast
28.52

TG Therapeutics reported $245.34M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 54.59B 1.62B Sep/2025
Ardelyx USD 207.61M 968K Sep/2025
Arrowhead Research USD 366.28M 13.25M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.29B 1.7M Dec/2025
Corcept Therapeutics USD 6.6M 2.03M Jun/2025
Dynavax Technologies USD 285.5M 24.99M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
PTC Therapeutics USD 286.32M 306K Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025